Entocort is an oral steroid recently approved for use in the treatment of Crohn's disease. The advantage of this preparation over other oral steroids is its formulation. The capsule delays the release of the steroid until it reaches the small intestine. This allows the use of a smaller dose than otherwise if it had to act systematically instead of locally. In addition the lower dose significantly reduces the incidence of side effects.
Description
Budesonide 3 mg cap. release.
Common uses
Mild to moderate Crohn's disease affecting the ileum or ascending colon.
Contraindications
Bacterial, fungal or viral infections. Children not recommended.
Dosage
Adults: 3 caps once daily in the morning before breakfast for up to 8 weeks.
| 
